Johann Gout

Albert Einstein Allee 23
Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Journal: Cancer treatment reviews

Published: May 01, 2026

Organoids at the Inflammation-Neoplasia Interface in Gallbladder Disease.

Organoids at the Inflammation-Neoplasia Interface in Gallbladder Disease.

Journal: Digestive diseases and sciences

Published: March 31, 2026

ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer.

ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer.

Journal: Cancer research

Published: January 09, 2026

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2025

A deep learning approach to assess transendothelial cell trafficking performance.

A deep learning approach to assess transendothelial cell trafficking performance.

Journal: Scientific reports

Published: July 03, 2025

Pancreatic organoids as cancer avatars for true personalized medicine.

Pancreatic organoids as cancer avatars for true personalized medicine.

Journal: Advanced drug delivery reviews

Published: April 05, 2025

Tumor microenvironment subtyping in pancreatic ductal adenocarcinoma: New avenues for personalized therapeutic strategies.

Tumor microenvironment subtyping in pancreatic ductal adenocarcinoma: New avenues for personalized therapeutic strategies.

Journal: Advanced drug delivery reviews

Published: March 28, 2025

DKK3 Initially Preserves Acinar Integrity Through MEK-Fos Signaling, but Later Switches to an Oncogenic Role in Pancreatic Cancer.

DKK3 Initially Preserves Acinar Integrity Through MEK-Fos Signaling, but Later Switches to an Oncogenic Role in Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 26, 2024

Organoid-based precision medicine in pancreatic cancer.

Organoid-based precision medicine in pancreatic cancer.

Journal: United European gastroenterology journal

Published: July 17, 2024

Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy.

Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy.

Journal: United European gastroenterology journal

Published: January 18, 2024

A Methodological Workflow to Analyze Synthetic Lethality and Drug Synergism in Cancer Cells.

A Methodological Workflow to Analyze Synthetic Lethality and Drug Synergism in Cancer Cells.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: July 22, 2022

RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia Initiation.

RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia Initiation.

Journal: Cellular and molecular gastroenterology and hepatology

Published: March 23, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026